John T. Potts, Jr., MD, is currently the Jackson Distinguished Professor of Clinical Medicine at Harvard Medical School. After medical training at the University of Pennsylvania, he completed his internship and residency at Massachusetts General Hospital. He went on to work at the National Institutes of Health (NIH), studying protein chemistry with Nobel laureate Christian Anfinsen. Dr. Potts remained at the NIH from 1959 until 1968, when he returned to the MGH as chief of endocrinology. The author or co-author of more than 500 scientific publications, he is a member of the National Academy of Sciences, the Institute of Medicine, and the American Academy of Arts and Sciences. He is also a director of ReceptorBase, Inc. and Zeltiq Aesthetics, a founder of Radius Health, Inc., and a member of the Scientific Advisory Boards of MPM Capital and HealthCare Ventures, as well as the Medical Advisory Board of Cell Genesys

• Parathyroid Hormone and Parathyroid Hormone-Related Peptide in the Regulation of Calcium Homeostasis and Bone DevelopmentCalcitoninVitamin D: From Photosynthesis, Metabolism, and Action to Clinical ApplicationsBone Development and RemodelingCalcium Regulation, Calcium Homeostasis, and Genetic Disorders of Calcium MetabolismGenetic Disorders of Phosphate HomeostasisPrimary HyperparathyroidismMalignancy-Associated Hypercalcemia and Medical ManagementSurgical Management of HyperparathyroidismPseudohypoparathyroidism, Albright's Hereditary Osteodystrophy, and Progressive Osseus Heteroplasia: Disorders Caused by Inactivating GNAS MutationsGenetic Defects in Vitamin D Metabolism and ActionHereditary Disorders of the SkeletonBone Density and Imaging of OsteoporosisChronic Kidney Disease Mineral and Bone DisorderDisorders of Calcification: Osteomalacia and RicketsPaget's Disease of Bone

John T. Potts, Jr., MD, is currently the Jackson Distinguished Professor of Clinical Medicine at Harvard Medical School. After medical training at the University of Pennsylvania, he completed his internship and residency at Massachusetts General Hospital. He went on to work at the National Institutes of Health (NIH), studying protein chemistry with Nobel laureate Christian Anfinsen. Dr. Potts remained at the NIH from 1959 until 1968, when he returned to the MGH as chief of endocrinology. The author or co-author of more than 500 scientific publications, he is a member of the National Academy of Sciences, the Institute of Medicine, and the American Academy of Arts and Sciences. He is also a director of ReceptorBase, Inc. and Zeltiq Aesthetics, a founder of Radius Health, Inc., and a member of the Scientific Advisory Boards of MPM Capital and HealthCare Ventures, as well as the Medical Advisory Board of Cell Genesys

• Parathyroid Hormone and Parathyroid Hormone-Related Peptide in the Regulation of Calcium Homeostasis and Bone DevelopmentCalcitoninVitamin D: From Photosynthesis, Metabolism, and Action to Clinical ApplicationsBone Development and RemodelingCalcium Regulation, Calcium Homeostasis, and Genetic Disorders of Calcium MetabolismGenetic Disorders of Phosphate HomeostasisPrimary HyperparathyroidismMalignancy-Associated Hypercalcemia and Medical ManagementSurgical Management of HyperparathyroidismPseudohypoparathyroidism, Albright's Hereditary Osteodystrophy, and Progressive Osseus Heteroplasia: Disorders Caused by Inactivating GNAS MutationsGenetic Defects in Vitamin D Metabolism and ActionHereditary Disorders of the SkeletonBone Density and Imaging of OsteoporosisChronic Kidney Disease Mineral and Bone DisorderDisorders of Calcification: Osteomalacia and RicketsPaget's Disease of Bone

John T. Potts, Jr., MD, is currently the Jackson Distinguished Professor of Clinical Medicine at Harvard Medical School. After medical training at the University of Pennsylvania, he completed his internship and residency at Massachusetts General Hospital. He went on to work at the National Institutes of Health (NIH), studying protein chemistry with Nobel laureate Christian Anfinsen. Dr. Potts remained at the NIH from 1959 until 1968, when he returned to the MGH as chief of endocrinology. The author or co-author of more than 500 scientific publications, he is a member of the National Academy of Sciences, the Institute of Medicine, and the American Academy of Arts and Sciences. He is also a director of ReceptorBase, Inc. and Zeltiq Aesthetics, a founder of Radius Health, Inc., and a member of the Scientific Advisory Boards of MPM Capital and HealthCare Ventures, as well as the Medical Advisory Board of Cell Genesys

• Parathyroid Hormone and Parathyroid Hormone-Related Peptide in the Regulation of Calcium Homeostasis and Bone DevelopmentCalcitoninVitamin D: From Photosynthesis, Metabolism, and Action to Clinical ApplicationsBone Development and RemodelingCalcium Regulation, Calcium Homeostasis, and Genetic Disorders of Calcium MetabolismGenetic Disorders of Phosphate HomeostasisPrimary HyperparathyroidismMalignancy-Associated Hypercalcemia and Medical ManagementSurgical Management of HyperparathyroidismPseudohypoparathyroidism, Albright's Hereditary Osteodystrophy, and Progressive Osseus Heteroplasia: Disorders Caused by Inactivating GNAS MutationsGenetic Defects in Vitamin D Metabolism and ActionHereditary Disorders of the SkeletonBone Density and Imaging of OsteoporosisChronic Kidney Disease Mineral and Bone DisorderDisorders of Calcification: Osteomalacia and RicketsPaget's Disease of Bone